Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/05/2012US20120172796 Composition for intravascular delivery of therapeutic composition
07/05/2012US20120172751 Assessment and Modulation of Cerebrospinal Fluid for Head Pain
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172455 Functionalized water-soluble polyphosphazenes and uses thereof as modifiers of biological agents
07/05/2012US20120172453 Methods for treating neurodegenerative diseases
07/05/2012US20120172452 Topical nitrone spin trap compositions for psoriasis
07/05/2012US20120172450 Use of jasmonate for improving skeletal muscle function
07/05/2012US20120172449 Polyamine transport inhibitors as novel therapeutics
07/05/2012US20120172448 Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof
07/05/2012US20120172447 Composition comprising vitamin u as active ingredient for healing skin wound
07/05/2012US20120172446 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
07/05/2012US20120172445 Nutritional products including a novel fat system including fatty acids
07/05/2012US20120172444 Use of Conjugated Linoleic Acid
07/05/2012US20120172443 Nutritional products including a novel fat system including monoglycerides
07/05/2012US20120172442 Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
07/05/2012US20120172438 Glycyrrhetinic acid ester derivative synthesis method and deoxoglycyrrhetinic acid ester compound
07/05/2012US20120172436 Liver Regeneration Accelerator Comprising Betaine
07/05/2012US20120172435 Methods for treating acute acoustic trauma
07/05/2012US20120172434 Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
07/05/2012US20120172432 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
07/05/2012US20120172431 Omega 3 fatty acid formulations
07/05/2012US20120172429 Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
07/05/2012US20120172427 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability
07/05/2012US20120172426 Compositions, Synthesis, and Methods of Using Cycloalkylmethylamine Derivatives
07/05/2012US20120172425 Red yeast rice extract high in monacolin k content
07/05/2012US20120172424 Chroman derivatives, medicaments and use in therapy
07/05/2012US20120172423 Compositions and methods for treating herpes simplex virus
07/05/2012US20120172422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid
07/05/2012US20120172421 2, 6 xylidine derivatives for the treatment of pain
07/05/2012US20120172420 Method for Modulating Responsiveness to Steroids
07/05/2012US20120172417 System And Method For Identifying And Applying Peripheral Treatment Mechanisms For Disease
07/05/2012US20120172416 Method for the preparation of micro-rna and its therapeutic application
07/05/2012US20120172415 Exon Skipping Therapy for Functional Amelioration of Semifunctional Dystrophin in Becker and Duchenne Muscular Dystrophy
07/05/2012US20120172414 Bicyclic cyclohexose nucleic acid analogs
07/05/2012US20120172413 Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same
07/05/2012US20120172411 Novel trialkyl cationic lipids and methods of use thereof
07/05/2012US20120172410 Short hairpin rna for gene knockdown of nr1 subunit of the n-methyl-d-aspartate receptor and its application on pharmaceutics
07/05/2012US20120172409 Methods and kits for linking polymorphic sequences to expanded repeat mutations
07/05/2012US20120172408 Active ingredient comprising indocyanine green and/or infracyanine green
07/05/2012US20120172406 Androgen receptor antagonists and uses thereof
07/05/2012US20120172405 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
07/05/2012US20120172402 Induction of alpha helix conformations in proteins and peptides
07/05/2012US20120172401 Benzimidazole derivative and use as angiotensin ii antagonist
07/05/2012US20120172400 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
07/05/2012US20120172399 Compounds as hypoxia mimetics, and composiitons and uses thereof
07/05/2012US20120172398 Co-crystals of tramadol and coxibs
07/05/2012US20120172397 HEXAHYDROCYCLOPENTA[f]INDAZOLE 5-YL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
07/05/2012US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors
07/05/2012US20120172395 Slow-release cilostazol tablet having an improved elution rate and minimal side effects
07/05/2012US20120172394 Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide
07/05/2012US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use
07/05/2012US20120172392 Amine-based and amide-based inhibitors of semicarbazide-sensitive amine oxidase (ssao) enzyme activity and vap-1 mediated adhesion useful for treatment of diseases
07/05/2012US20120172391 Naphthyridinone analogs as mglur5 positive allosteric modulators
07/05/2012US20120172390 Method of treating sleep disorders using the combination of eplivanserin and zolpidem
07/05/2012US20120172389 Treatment of fibrosing disorders
07/05/2012US20120172388 Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor
07/05/2012US20120172387 Opioids for the treatment of the restless leg syndrome
07/05/2012US20120172386 Combinations Comprising a VEGF Receptor Inhibitor
07/05/2012US20120172385 Ortho substituted pyrimidine compounds as jak inhibitors
07/05/2012US20120172384 Heterocyclylaminopyrimidines as kinase inhibitors
07/05/2012US20120172382 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
07/05/2012US20120172381 Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors
07/05/2012US20120172380 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
07/05/2012US20120172379 4 substituted pyrazolopyrimidines
07/05/2012US20120172378 Novel compounds
07/05/2012US20120172377 Pyrido[4,3-b]indoles and methods of use
07/05/2012US20120172376 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012US20120172375 Compounds and methods of promoting oligodendrocyte precursor differentiation
07/05/2012US20120172374 Novel tubulin inhibitors and methods of using the same
07/05/2012US20120172373 Method of treating cognitive impairments and schizophrenias
07/05/2012US20120172372 Ureas and Their Use in the Treatment of Heart Failure
07/05/2012US20120172371 Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (tdp1)
07/05/2012US20120172370 Preparation of crystalline forms of dihydropyrazolopyrimidinone
07/05/2012US20120172369 Inhibitors of diacylglycerol acyltransferase
07/05/2012US20120172368 Bis-Benzimidazole Derivatives
07/05/2012US20120172367 Macrocyclic integrase inhibitors
07/05/2012US20120172366 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
07/05/2012US20120172365 Use of phosphordiesterase inhibitors in the treatment of prostatic diseases
07/05/2012US20120172364 Rate-controlled particles
07/05/2012US20120172363 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers
07/05/2012US20120172362 Therapeutic agent for anxiety disorders
07/05/2012US20120172361 Triazine derivatives and their therapeutical applications
07/05/2012US20120172360 Novel 1h-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of akt (pkb) phosphorylation
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172358 GPCR Agonists
07/05/2012US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/05/2012US20120172356 Serum biomarkers for chagas disease
07/05/2012US20120172355 Aminodihydrothiazine derivatives substituted with a cyclic group
07/05/2012US20120172354 Substituted N-Phenyl-1-(4-Pyridinyl)-1H-Pyrazol-3-Amines
07/05/2012US20120172353 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172351 Novel fused cyclic compound and use thereof
07/05/2012US20120172350 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/05/2012US20120172349 Therapeutic compounds and compositions
07/05/2012US20120172348 Sterol derivative
07/05/2012US20120172347 8-oxodihydropurine derivative
07/05/2012US20120172346 Use of nicotinic acetylcholine receptor alpha 7 activators
07/05/2012US20120172345 Heteroaryls and uses thereof
07/05/2012US20120172344 Insulin-producing cell inducer, glucose intake enhancer, and therapeutic agent for diabetes or diabetes complications
07/05/2012US20120172343 Pharmaceutical composition for emergency contraception
1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 7860